Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Zynerba Pharmaceuticals Q4 EPS $(0.22) Up From $(0.33) YoY

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.22) per share. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year.
byBill Haddad
March 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.22) per share. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Tsakos Energy Navigation

By Benzinga Insights
Today, 10:59 AM
Tsakos Energy Navigation (NYSE:TNP) is set to give its latest quarterly earnings report on Thursday, 2021-12-16. Here's what investors need to know before the announcement. Analysts estimate that Tsakos Energy Navigation will likely report an Earnings Per Share (EPS) of $-1.12.

TNP